Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Unexpected Progress from Head Massage and Minoxidil

      in Treatment  20 upvotes 10 months ago
      The user experienced unexpected hair volume increase after combining scalp massages with topical minoxidil and oral finasteride. They plan to continue this regimen, noting a reduction in hair shedding.

      community Scalp, eyebrow, eyelash and pubic hair loss.

       7 upvotes 8 years ago
      The user experienced significant hair loss on the scalp, eyebrows, eyelashes, and pubic area, along with itchy, flaky skin and red patches. They have a history of eczema and dermatitis and suspect that stopping shampoo use and taking Ritalin may have contributed to the issue.

      community Anyone else just dump Minoxidil wherever

      in Chat  137 upvotes 4 months ago
      Minoxidil is applied beyond the crown, including the hairline and other areas, despite labels suggesting crown use only. Users report success with broader application, and some prefer oral minoxidil for convenience.

      community Alcohol-free minoxidil available in Europe

      in Minoxidil  5 upvotes 6 months ago
      Alcohol-free minoxidil options in Europe, particularly from a German pharmacy, are recommended for those with seborrheic dermatitis. Users suggest alternatives like Alopexy and Doppelherz foam, and emphasize avoiding propylene glycol and alcohol to reduce irritation.

      community 14 months - 1mg fin & 5% topical minoxidil results

      in Progress Pictures  452 upvotes 1 month ago
      Significant hair regrowth was achieved using 1mg finasteride and 5% topical minoxidil over 14 months, with only initial shedding and mild scalp irritation as side effects. Consistency and early treatment are recommended for optimal results.

      community A concern regarding the upcoming androgen degrader drug GT20029

      in Chat  11 upvotes 1 year ago
      GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.